Vimarsana
Biggest News Aggregation in the World

Page 13 - Home Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Home Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Home Diagnostics Today - Breaking & Trending Today

Home Diagnostics for Urinary Tract Infection Market is expected to reach US$ 1,354.02 Mn With CAGR of 6.2% from 2020 to 2027 - Vimarsana News

Home Diagnostics for Urinary Tract Infection Market is expected to reach US$ 1,354.02 Mn With CAGR of 6.2% from 2020 to 2027

Home Diagnostics for Urinary Tract Infection Market is expected to reach US$ 1,354.02 Mn With CAGR of 6.2% from 2020 to 2027

AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors - Vimarsana News

AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors - read this article along with other careers information, tips and advice on BioSpace

Lasting Impact of Covid: Fewer Doctor's Office Visits Thanks to At-Home Diagnostics - Vimarsana News

Lasting Impact of Covid: Fewer Doctor's Office Visits Thanks to At-Home Diagnostics

While treatment has long been viewed as the central role of our healthcare system, the COVID-19 pandemic brought diagnostics to center stage. Early and ...

AVITA Medical, Inc. Appoints Two New Non-Executive Members - Vimarsana News

AVITA Medical, Inc. Appoints Two New Non-Executive Members

VALENCIA, Calif. and MELBOURNE, Australia, June 01, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a...

Morepen EGM approves Rs.433 cr incoming investment from Corinth and promoters - Vimarsana News

Morepen EGM approves Rs.433 cr incoming investment from Corinth and promoters

  New Delhi: Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288), a leading manufacturer of high-quality APIs, Home Diagnostics, Formulations and OTC products, yesterday approved incoming investment of Rs. 433 crore in the Extra-Ordinary General Meeting (EGM) of the company. The members approved the issue and allotment of 58.50 million equity shares for cash to Corinth Investment Holdings AG, Switzerland (www.corinthinvest.com) at Rs.41.60 per share aggregating to Rs. 243.36 crores.   Shareholders also approved 50 million fully convertible warrants to a promoter group company Liquid...